DOUGLAS Group Increases Sales Forecast and Sells Online Pharmacy Disapo

DOUGLAS Group has raised its sales forecast for the financial year 2023/24 to 8.5%, up from a previous estimate of 7%. This update comes on the back of robust business performance with the group's net sales rising by 7.3% in Q3 2024, driven by a 7.2% increase in store sales and a 7.5% boost in E-Commerce.

In the first nine months of the financial year, from October 2023 to June 2024, net sales increased by 8.7% to €3.5 billion. This growth was balanced between an 8.2% rise in store sales and a 9.8% increase in E-Commerce, highlighting the effectiveness of the group's omnichannel model.

CEO Sander van der Laan expressed satisfaction with these results, noting significant progress and an expectation for continued profitability improvement. The company's mid-term goal remains an adjusted EBITDA margin of approximately 18.5%.

Additionally, DOUGLAS Group has signed an agreement to sell its online pharmacy Disapo to MYA Health B.V., marking a strategic shift to concentrate on its core premium beauty business. This transaction is expected to conclude by the end of July 2024.